- Home
- DRMA vs ACON Comparison
DRMA vs ACON Comparison
Compare DRMA & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRMA
- ACON
- Stock Information
- Founded
- DRMA 2014
- ACON 2008
- Country
- DRMA United States
- ACON United States
- Employees
- DRMA N/A
- ACON N/A
- Industry
- DRMA Biotechnology: Pharmaceutical Preparations
- ACON Retail: Computer Software & Peripheral Equipment
- Sector
- DRMA Health Care
- ACON Technology
- Exchange
- DRMA Nasdaq
- ACON Nasdaq
- Market Cap
- DRMA 4.5M
- ACON 4.8M
- IPO Year
- DRMA 2021
- ACON 2022
- Fundamental
- Price
- DRMA $0.75
- ACON $7.64
- Analyst Decision
- DRMA Strong Buy
- ACON Buy
- Analyst Count
- DRMA 1
- ACON 2
- Target Price
- DRMA $6.00
- ACON $481.00
- AVG Volume (30 Days)
- DRMA 4.2M
- ACON 75.1K
- Earning Date
- DRMA 05-14-2025
- ACON 04-09-2025
- Dividend Yield
- DRMA N/A
- ACON N/A
- EPS Growth
- DRMA N/A
- ACON N/A
- EPS
- DRMA N/A
- ACON N/A
- Revenue
- DRMA N/A
- ACON $45,724.00
- Revenue This Year
- DRMA N/A
- ACON $251.35
- Revenue Next Year
- DRMA N/A
- ACON N/A
- P/E Ratio
- DRMA N/A
- ACON N/A
- Revenue Growth
- DRMA N/A
- ACON N/A
- 52 Week Low
- DRMA $0.69
- ACON $7.26
- 52 Week High
- DRMA $6.17
- ACON $6,241.05
- Technical
- Relative Strength Index (RSI)
- DRMA 34.82
- ACON 33.40
- Support Level
- DRMA $0.69
- ACON $8.15
- Resistance Level
- DRMA $0.85
- ACON $8.30
- Average True Range (ATR)
- DRMA 0.08
- ACON 1.25
- MACD
- DRMA -0.00
- ACON 6.41
- Stochastic Oscillator
- DRMA 21.43
- ACON 6.94
About DRMA Dermata Therapeutics Inc.
Dermata Therapeutics Inc. is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its two product candidates, DMT310 and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to development and formulation of singular and combination products that can target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases.
About ACON Aclarion Inc.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.